Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
Sales | 28 | 30 | 37 | 240 | 451 |
Gross Profit | 28 | 30 | 37 | 240 | 451 |
Operating Expenses | 21,751 | 17,988 | 12,202 | 11,051 | 9,608 |
Operating Income | -21,723 | -17,958 | -12,165 | -10,811 | -9,157 |
Other Income | 228 | 130 | 116 | 116 | 76 |
Pre-tax Income | -21,495 | -17,828 | -12,049 | -10,695 | -9,081 |
Net Income Continuous | -21,495 | -17,828 | -12,049 | -10,695 | -9,081 |
Net Income | $-21,495 | $-17,828 | $-12,049 | $-10,695 | $-9,081 |
EPS Basic Total Ops | -0.22 | -0.19 | -0.13 | -0.12 | -0.11 |
EPS Basic Continuous Ops | -0.22 | -0.19 | -0.14 | -0.12 | -0.11 |
EPS Diluted Total Ops | -0.22 | -0.19 | -0.13 | -0.12 | -0.11 |
EPS Diluted Continuous Ops | -0.22 | -0.19 | -0.14 | -0.12 | -0.11 |
EBITDA(a) | $-22,003 | $-17,604 | $-11,536 | $-10,330 | $-8,817 |